Validation pour Ingenuity308

vers la météo de la validation par utilisateur

Ingenuity308

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 87 - PMID ?

In SP kidney , intraperitoneal administration of NODE ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of SP Peroxisomal NODE [NODE] mRNA .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 1

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 2

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 3

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 4

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 5

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 6

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 7

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 8

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 9

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 10

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 11

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 12

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 13

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 14

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 15

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 16

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 17

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 18

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 19

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 20

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 21

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                                                                     +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 22

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 23

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 24

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 25

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 26

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                                                                     +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 27

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 28

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 29

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 30

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                               |            |                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 31

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 32

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 33

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 34

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 35

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |                                   |                                                                     +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 36

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 37

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 38

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |                                   |                                                                     +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 39

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 40

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 41

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 42

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 43

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 44

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 45

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 46

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 47

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 48

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 49

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 50

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 51

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 52

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 53

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 54

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 55

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 56

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 57

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 58

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 59

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 60

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 61

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 62

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 63

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 64

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 65

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 66

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 67

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 68

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 69

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 70

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 71

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |                                   |                                                                     +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 72

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 73

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 74

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 75

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 76

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |                                   |                                                                     +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 77

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 78

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 79

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 80

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 81

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 82

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 83

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 84

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 85

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 86

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 87

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 88

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 89

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 90

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 91

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 92

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 93

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 94

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 95

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 96

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 97

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 98

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |                    +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 99

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 100

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |                   +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |                   |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |                   |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 101

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |           +------------MOD_ATT:N-ADJ------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           |        +---------MOD_ATT:N-N--------+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+           |        |                    +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |                    |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 102

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 103

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +----------COMP:N-N(of)---------+                 |   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 104

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 105

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 106

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 107

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 108

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 109

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 110

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 111

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 112

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 113

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 114

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 115

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 116

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                               |            +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 117

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 118

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 119

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 120

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 121

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 122

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 123

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                               +------------------COMP:N-N(of)------------------+           |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 124

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 125

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 126

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 127

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 128

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 129

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 130

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 131

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 132

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 133

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 134

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 135

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 136

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 137

       +--------------------------------------------------------COMP:V_PASS-N(In)-------------------------------------------------------+                                                                  
       |                                   +----------------------------------------SUBJ:V_PASS-N---------------------------------------+            +-------------------COMP:N-N(of)------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            |                    +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |                    |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V_PASS-+                    |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |                    |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V_PASS-N(In) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 138

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 139

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 140

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 141

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 142

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                 +---------MOD_ATT:N-N--------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 143

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |            +----------COMP:N-N(of)---------+                 |   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            |           +---MOD_ATT:N-ADJ---+                 |   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           |        +MOD_ATT:N-+         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,Peroxisomal)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 144

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 145

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +-------------COMP:N-N(of)------------+                      |                                                                  
       |                                   |                               |            +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               |            |                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 146

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 147

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 148

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                                                                     +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 149

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                               +------------------COMP:N-N(of)------------------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+          |           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (dosage,day)
MOD_ATT:N-N (period,treatment)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 150

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 151

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 152

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 153

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                               +-------------COMP:N-N(of)------------+COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+                +COMP:N-N(of)+               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |                |            |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(of) (dosage,mg/kg/day)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 154

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 155

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |                   +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |                   |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 156

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 157

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 158

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 159

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 160

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 161

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 162

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-ADJ (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 163

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+----------------------------OBJ:V-N---------------------------+   
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                 +---------MOD_ATT:N-N--------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |                                 |          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+COMP:N-N(of+        |          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-N (mRNA,Peroxisomal)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 164

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 165

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      |                                                                  
       |                                   |                       |                    +------------COMP:N-N(of)-----------+           +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 166

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])

Analyse 167

       +----------------------------------------------------------COMP:V-N(In)----------------------------------------------------------+                                                                  
       |                                   +------------------------------------------SUBJ:V-N------------------------------------------+                                                                  
       |                                   |                       +-------------------OBJ:V-N-------------------+                      +----------------------------OBJ:V-N---------------------------+   
       |      +---------MOD_ATT:N-N--------+                       +-------OBJ:V-N------+                        +COMP:N-N(o+           |            +----COMP:N-N(of)----+          +--MOD_ATT:N-ADJ--+   
       |      |            +-MOD_ATT:N-ADJ-+-COMP:N-N(of)-+        |       +COMP:N+     |               +MOD_ATT:+      +MOD+           +COMP:V-N(in)+           +MOD_ATT:+          |         +MOD_ATT+   
       |      |            |               |              |        |       |      |     |               |        |      |   |           |            |           |        |          |         |       |   
 In __SP__ kidney , intraperitoneal administration of __NODE__ ( with a dosage of 1 mg/kg/day and a treatment period of 7 days ) is involved in expression of __SP__ Peroxisomal __NODE__ [__NODE__] mRNA .
MOD_ATT:N-N (administration,kidney)
MOD_ATT:N-ADJ (administration,intraperitoneal)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,administration)
COMP:V-N(in) (involve,expression)
OBJ:V-N (involve,mRNA)
COMP:N-N(of) (expression,Peroxisomal)
MOD_ATT:N-N (Peroxisomal,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (mRNA,[__NODE__])